The condition can range from mild inflammation managed with supportive care to severe cases requiring antibiotics, hospitalisation or surgery
Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts
Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead
The reason why this medication causes nausea isnt completely understood
Most evidence comes from wound healing studies, general dermatological research, and mechanistic data extrapolated to eczema pathology
Most patients notice improved energy levels within the first 1-2 weeks
